Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil - Wikidata - wikimedia - TriplyDB

Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil

Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil

http://www.wikidata.org/entity/Q34478766

about

Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor Synthesis and release of Hageman factor (Factor XII) by the isolated perfused rat liver.Partial purification and characterization of contact activation cofactor.Antiphospholipid antibodies and kininogens in pathologic pregnancies: a review.Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.A brief historical review of the waterfall/cascade of blood coagulation.Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen.The induction of macrophage spreading: role of coagulation factors and the complement system Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.Purification of high molecular weight kininogen and the role of this agent in blood coagulation.Association of factor XI and high molecular weight kininogen in human plasma.Plasma kallikrein activation and inhibition during typhoid fever.Mechanism of the participation of the contact system in the Vroman effect. Review and summary.Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate.Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens Historical perspective and future direction of coagulation research.Kininogen-dependent antiphosphatidylethanolamine antibodies and autoantibodies to factor XII in patients with recurrent pregnancy losses.The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.Relation between structure and correcting activity of bovine high molecular weight kininogen upon the clotting time of Fitzgerald-trait plasma.Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity.The significance of high molecular weight kininogen for contact activation of rat blood coagulation, in vitro.Circulating plasma prekallikrein and tissue kallikrein in normotensive and hypertensive humans: effects of angiotensin II infusion.Human H-kininogen is a ferritin-binding protein.

P2860

Q24634211-00A0EB69-753C-45DA-A9AB-CCBC86A14E7C Q28628750-02F00B96-9BCC-4BD3-928A-11FF47CD29EF Q33822295-F36105F3-D82A-45E3-BD40-6372605653CC Q34483720-343E296E-AEDC-4A2D-AF81-B8D633372936 Q34767031-FD886DE5-3D4A-404D-AA95-AD80759D2FEC Q35037706-844EA67D-245F-4E26-A33C-63FF46444597 Q35058622-19D203FF-8F6F-4E99-8751-BEF14FF0ABBB Q35564946-FA3200B2-7817-4904-B53C-03D33F44BE9D Q35905313-09C16A06-1479-494A-B3A7-DBC76A5659AE Q36312684-6538DADC-DAFC-4D20-A5AA-478E400B08E8 Q36340730-8926A2BF-B7CD-45ED-ABF2-0C65324FC763 Q36360057-21814D5B-BF09-4621-972B-C6E01A595956 Q37020391-58D5B213-46A0-444A-8277-FFA55509EA47 Q37029588-6028AAF6-BAF2-468B-AD0C-D8847F87D736 Q37038122-BE96F385-25B4-497F-BE16-8E131BF90E5A Q37045271-CAF39AC2-6ADC-4995-BA16-04A246BA7582 Q37045297-7844EE09-7CCD-419F-B5E2-3ADB4B79A069 Q37046520-3C138E97-46A0-4136-94BF-220A22322BBA Q37046547-2FC12613-A2FC-42D1-9AE7-B342F6E11C12 Q37049066-73B799B1-4279-40B2-8FB9-3AA803004CAC Q37050492-F39B821C-B14D-4721-86E1-061C8EBD7460 Q37188939-F83C088E-AE21-4A45-BA27-C8FFB113C9D0 Q37312644-16D27DEA-5DF4-46DE-8413-9581E4C17A8E Q37316920-A9509688-CA3A-42AC-9414-31CF4149CE9C Q37584724-1058BAE3-B49B-43C9-9918-537A563739EF Q37616021-6313825D-B139-4001-9D43-9BB06B848F8B Q37903961-1695C785-0DDE-49DB-A1EC-07D639F824C7 Q38117200-B8CABE66-2983-42C1-9A83-83E81AA7CFDC Q40690900-6EEA9E9E-46A5-4B74-86D9-7A98B9F415B2 Q41503894-F0F8FB4C-8DF6-40A7-85DE-A82AF51529A1 Q42029798-6388D078-2FD7-4BD5-9903-17E39ADF649F Q47449846-56BF65CD-D1CB-4274-8D81-6891C7C8E683 Q48031547-FAE7C237-A1E0-4587-AFE0-1DE38A66782A Q54546044-2BAAB410-3A5E-4B45-AAA4-7B786A97E676

P2860

Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil

http://www.wikidata.org/entity/Q34478766

description

1975 nî lūn-bûn

@nan

1975 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1975 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1975年の論文

@ja

1975年論文

@yue

1975年論文

@zh-hant

1975年論文

@zh-hk

1975年論文

@zh-mo

1975年論文

@zh-tw

1975年论文

@wuu

name

Fitzgerald Trait: Deficiency o ...... Vascular Permeability (PF/Dil

@ast

Fitzgerald Trait: Deficiency o ...... Vascular Permeability (PF/Dil

@en

Fitzgerald Trait: Deficiency o ...... Vascular Permeability (PF/Dil

@nl

type

label

Fitzgerald Trait: Deficiency o ...... Vascular Permeability (PF/Dil

@ast

Fitzgerald Trait: Deficiency o ...... Vascular Permeability (PF/Dil

@en

Fitzgerald Trait: Deficiency o ...... Vascular Permeability (PF/Dil

@nl

prefLabel

Fitzgerald Trait: Deficiency o ...... Vascular Permeability (PF/Dil

@ast

Fitzgerald Trait: Deficiency o ...... Vascular Permeability (PF/Dil

@en

Fitzgerald Trait: Deficiency o ...... Vascular Permeability (PF/Dil

@nl

P1433

Q34478766-1FE1161F-DD83-47D2-B186-C24816CA7690

P1476

Q34478766-BB17778A-305E-4B1B-98BA-643284D5B22A

P2093

Q34478766-2FB154E1-81FE-4D78-AFFA-8E25F6DC8861

Q34478766-A2DE44E9-51E8-44EB-9840-19BC130E5411

Q34478766-C40822F2-0BB7-42B6-991C-E008E0498F90

Q34478766-CC8E4B64-683B-445B-80A4-46DE619A29FF

P2860

Q34478766-16D33B6F-69E4-4FC5-9A2B-18FF8957DFC4

Q34478766-18710036-4224-4D6E-B72B-31A7BCD20C77

Q34478766-2619F439-73AA-43F2-8D07-68F8EAD01C5D

Q34478766-27E9FFA4-E3A1-4D13-BD4A-0A9CFE287DCD

Q34478766-547BFF37-6478-49BA-8904-672D85F51487

Q34478766-599CDB7A-6198-454B-8E61-BFEDE73477C6

Q34478766-6ED29D8D-6B81-4B08-AACB-CBA5CA572F8F

Q34478766-9E3125B1-0FC4-40AC-9E3B-96CF087148B2

Q34478766-A75BCDC0-6259-4D4E-971B-6585BC5B4BF4

Q34478766-D60A93A6-965B-47B9-9A2F-A211394DFC7F

P304

Q34478766-B038ADCE-48DE-4276-A179-A95676C7D26D

P31

Q34478766-D032407B-0C52-4764-AF32-71F3AABB26CA

P356

Q34478766-1D91483F-5EE2-4228-AF3D-3A8A4730D148

P407

Q34478766-AE61862B-54D5-4895-BD2B-C9B73E0BC116

P433

Q34478766-A7080972-DB57-4539-8EA6-F42A6D3DC2A0

P478

Q34478766-FC9AFA00-8125-4FFE-A86D-B4A7859FCDFE

P577

Q34478766-B8A55FFE-FCD6-4AB2-A7A3-ECB3D88CC442

P698

Q34478766-5D2374BF-8153-4706-A1BB-01E9352B5B85

P932

Q34478766-51DA4E3D-AE65-439F-AEC1-6A63127690B4

P356

P1433

Journal of Clinical Investigation

P1476

Fitzgerald Trait: Deficiency o ...... Vascular Permeability (PF/Dil

@en

P2093

Abraham JP

http://www.w3.org/2001/XMLSchema#string

Ratnoff OD

http://www.w3.org/2001/XMLSchema#string

Saito H

http://www.w3.org/2001/XMLSchema#string

Waldmann R

http://www.w3.org/2001/XMLSchema#string

P2860

Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.

Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant agains

Kinins: possible mediators of neonatal circulatory changes in man

Studies on kallikrein: failure of some anti-inflammatory drugs to affect release of kinin.

Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.

The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.

Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum.

Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.

THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR.

The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states.

P304

1082-1089

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI108009

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

1975-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16695963

http://www.w3.org/2001/XMLSchema#string

P932

301855

http://www.w3.org/2001/XMLSchema#string